ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host a Third Quarter 2019 conference call and webcast on Friday, November 8, 2019, at 2:30 PM CET/8:30 AM EST to discuss operational highlights.
